IMA ImageneBio Inc
Healthcare$5.82+4.68%ClosedMarket Cap: $65.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.51
P/S
0.00
EV/EBITDA
0.10
DCF Value
$4.99
FCF Yield
-83.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-35.2%
ROA
-33.0%
ROIC
-42.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-12.1M | $-10.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-8.5M | $-6.9M | $— | — |
| FY null | $800.0K | -29.1% | $-48.5M | $-45.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-26.6M | $-24.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-8.8M | $-2.8M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-10.8M | $-8.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-12.5M | $-9.1M | $— | — |
| FY null | $3.5M | 100.0% | $-37.0M | $-36.6M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-12.4M | $-10.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-15.8M | $-13.7M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-18.2M | $-16.1M | $— | — |
| Q4 2023 | $659.0K | 53.7% | $-21.9M | $-19.5M | $-0.41 | — |